Edentulous jaw
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients voluntarily participate in the clinical trial and sign an informed consent form; 2.Aged 18–70 years (inclusive), of any gender; 3.Suffering from complete tooth loss requiring full-arch implant restoration and meeting the indications for dental implant surgery; 4.Good compliance, willing and able to attend follow-up visits as required; 5.Edentulous space, jaw relationship, and other relevant factors meet prosthetic requirements.
Exclusion criteria
Exclusion criteria: 1.Individuals who have participated in other medical technology trials within the past 3 months; 2.Patients allergic to any material used in the product; 3.Patients with uncontrolled endocrine or metabolic disorders, hematological diseases, or cardiovascular diseases; 4.Systemic or local bone disorders; 5.Individuals with systemic autoimmune diseases; 6.Neurological disorders, such as epilepsy; 7.Psychiatric disorders or psychological impairments; 8.Pathological mucosal lesions; 9.Post-radiotherapy to the head or neck; 10.Uncontrolled periodontal disease or extremely poor oral hygiene; 11.Parafunctional habits such as bruxism; 12. Insufficient bone volume and/or poor bone quality; 13.Maxillary or mandibular hypoplasia or pathological changes; 14.Xerostomia; 15.Pregnant or lactating women; 16.Long-term use of special medications such as hormones or anticoagulants; 17.Patients with alcohol or drug addiction; 18.Any other conditions that the investigator considers unsuitable for the trial;
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Implant Success Rate; | — |
Primary
| Measure | Time frame |
|---|---|
| Implant Placement Accuracy ;Implant Success Rate; | — |
Countries
China
Contacts
West China Hospital of Stomatology, Sichuan University